Document Detail

Efficacy of Cilostazol in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention.
MedLine Citation:
PMID:  22975664     Owner:  NLM     Status:  Publisher    
The objective of this study was to explore the long-term effect of cilostazol-optimized antiplatelet therapy after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS). One hundred forty-six patients with ACS who underwent PCI were enrolled. Patients were randomly divided into 2 groups based on clot rate (CR), and both groups received antiplatelet therapy: aspirin and clopidogrel plus cilostazol (intensification group, n = 72) or aspirin and clopidogrel (control group, n = 74). Clinical follow-up was up to 12 months after PCI. During follow-up, CR was determined at day 1 and at 1, 3, 6, and 12 months post-PCI. Efficacy endpoints included second acute myocardial infarction, in-stent thrombosis, revascularization (second PCI), sudden death, and hemorrhage. CR was significantly lower in the intensification group than in the control group at 1, 3, and 6 months after PCI (P < 0.05). The incidences of second acute myocardial infarction, in-stent thrombosis, revascularization (second PCI), and sudden cardiac death were also lower but insignificant; there were no hemorrhage events (P > 0.05). Cilostazol-optimized antiplatelet therapy can significantly decrease CR after PCI in patients with acute coronary syndrome.
Taohong Hu; Huili Ma; Huijun Li; Jianghua Ren
Related Documents :
23261004 - Relation of body fat categories by gallagher classification and by continuous variables...
2220574 - Sensitivity of a set of myocardial infarction screening criteria in patients with anato...
24365794 - A comparison of clinical features of coronary artery spasm with and without thyrotoxico...
24353574 - Cardioprotective effects of atorvastatin plus trimetazidine in percutaneous coronary in...
21720264 - In-treatment stroke volume predicts cardiovascular risk in hypertension.
1414894 - Electrolyte balance in heart failure and the role for magnesium ions.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-12
Journal Detail:
Title:  American journal of therapeutics     Volume:  -     ISSN:  1536-3686     ISO Abbreviation:  Am J Ther     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9441347     Medline TA:  Am J Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Cardiology, Second Affiliated Hospital of Wuhan University, Wuhan, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A Study of Elderly Patients With Limited-Stage Small-Cell Lung Cancer After Combined Chemoradiothera...
Next Document:  Neurologic symptoms associated with cattle farming in the agricultural health study.